» Articles » PMID: 18039425

Intensity-modulated Radiation Therapy for the Treatment of Anal Cancer

Overview
Publisher Elsevier
Date 2007 Nov 28
PMID 18039425
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The aim of this study was to assess whether intensity-modulated radiation therapy (RT; IMRT) can reduce dose to normal tissues (organs at risk) while maintaining equivalent target coverage.

Patients And Methods: A 9-field, non-coplanar, 1-cm beamlet IMRT plan was designed for 9 patients who were previously treated for anal cancer with conventional field arrangements. Clinical target volumes and organs at risk (OARs) were defined. Target coverage was assigned highest priority for optimization, followed sequentially by organ at risk. The genitalia and perineal skin were the highest priority OARs. Lexicographic ordering-based IMRT optimization was used to generate a conformal plan, which was compared with the conventional, previously delivered RT plan.

Results: The IMRT and conventional RT plan achieved homogeneous dose coverage of all target volumes. Intensity-modulated RT produced highly conformal dose distributions compared with conventional techniques, with avoidance of critical normal structures. Statistically significant reductions in mean doses to the perineal skin and to the genitalia were seen with IMRT, with only a modest increase in mean dose to the bony pelvis.

Conclusion: Intensity-modulated RT, with lexicographic ordering, allows for substantial reduction of dose to OARs while maintaining adequate target coverage. These encouraging findings might translate into reductions of treatment-related toxicity, gains in local control, or improvements in quality of life.

Citing Articles

Toxicity and survival of anal cancer patients treated with intensity-modulated radiation therapy.

Ghareeb A, Paramasevon K, Mokool P, Van der Voet H, Jha M Ann R Coll Surg Engl. 2018; 101(3):168-175.

PMID: 30482037 PMC: 6400906. DOI: 10.1308/rcsann.2018.0202.


Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Benson A, Venook A, Al-Hawary M, Cederquist L, Chen Y, Ciombor K J Natl Compr Canc Netw. 2018; 16(7):852-871.

PMID: 30006428 PMC: 10181270. DOI: 10.6004/jnccn.2018.0060.


Volumetric intensity-modulated arc therapy vs. 3-dimensional conformal radiotherapy for primary chemoradiotherapy of anal carcinoma: Effects on treatment-related side effects and survival.

Weber H, Droge L, Hennies S, Herrmann M, Gaedcke J, Wolff H Strahlenther Onkol. 2015; 191(11):827-34.

PMID: 26050046 DOI: 10.1007/s00066-015-0859-6.


Proposed genitalia contouring guidelines in anal cancer intensity-modulated radiotherapy.

Brooks C, Hansen V, Riddell A, Harris V, Tait D Br J Radiol. 2015; 88(1051):20150032.

PMID: 25955229 PMC: 4628528. DOI: 10.1259/bjr.20150032.


IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center.

Vieillot S, Fenoglietto P, Lemanski C, Llacer Moscardo C, Gourgou S, Dubois J Radiat Oncol. 2012; 7:45.

PMID: 22445137 PMC: 3342212. DOI: 10.1186/1748-717X-7-45.